Primary Country (Mandatory)

United States

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
English
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
English
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
CNN
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
AajTak
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
MoreBack to News Headlines
Sanofi gets approval for alternative inactivated polio vaccine

Sanofi gets approval for alternative inactivated polio vaccine

The Hindu
Friday, April 5, 2024 12:35 AM GMT

Only recently, activists, public health experts, tuberculosis (TB) survivors, and people living with HIV had sought Prime Minister Narendra Modi’s intervention to halt what they said were frequent shortages in the availability of anti-TB drugs.

After the French drugmaker Sanofi India Limited recently discontinued ShanIPV, its inactivated polio vaccine (IPV), in India, the company has confirmed that it will ensure there is no interruption in the availability its IPV vaccine.

“We have already obtained the approvals for our product, IMOVAX-Polio, an alternative IPV that has been in use in more than 100 countries for 40-plus years. It also has the same composition/formulation as ShanIPV,” the company’s spokesperson said, following widespread concern that a pull out could lead to shortage of the vaccine in India.

Only recently, activists, public health experts, tuberculosis (TB) survivors, and people living with HIV had sought Prime Minister Narendra Modi’s intervention to halt what they said were frequent shortages in the availability of anti-TB drugs.

“There will be no shortage of IPV vaccines in India on our account, and towards safeguarding the nation’s status of remaining polio-free. We remain fully committed to fulfilling our public health mission in India,” the company said.

Sanofi India caters to a significant part of India’s injectable poliomyelitis vaccine needs. While the Union Health Ministry was unavailable for comment on the matter, Sanofi India had in 2023 issued a public notice to announce its decision to initiate the closure of ShanIPV, and apply for regulatory approval for a product with a similar composition.

Explaining its withdrawal of ShanIPV, Sanofi India said that the COVID-19 pandemic had accelerated the speed at which the healthcare sector had evolved both in India and globally, resulting in the emergence of new pharmaceutical manufacturers, and increased supply capacities in both vaccines and medicines.

As a result, Sanofi has had to adapt its strategy and portfolio to these trends. Accordingly, Sanofi Healthcare India Private Limited announced that, by the end of 2023, it would discontinue ShanIPV, which was only filled and packaged at their factory in Hyderabad. The antigens for the polio vaccine were manufactured in France.

Read full story on The Hindu
Share this story on:-
Run 3 Space | Play Space Running GamePlay Run 3, the ultimate space tunnel running game with 300+ challenging levels!Adv.
Traffic Jam 3D | Online Racing GameTraffic Jam 3D is a game where you’ll be driving through heavy traffic.Adv.
Duck Hunt | Play Old Classic GamePlay the classic 1984 light gun shooter game Duck Hunt on your browser.Adv.
More Related News
Parking Slot | Free Parking GamePlay Parking Slot, the best online 3D car driving and parking game.Adv.
Slope Ball Run - Play OnlineSlope Game takes you on an exciting journey of a ball on special paths.Adv.
Tesla’s monthly sales in Europe plunge by half, signalling backlash against Musk runs deep

Tesla has been reeling from protests and boycotts over Musk wading into politics.

Picture of the week: The superhumans of Mumbai

In Mallakhamb, a traditional performative sport from India, performers balance themselves on a pole and perform acrobatics.

Thailand’s Opal Suchata Chuangsri crowned Miss World 2025 in a dazzling grand finale in Hyderabad

The 72nd Miss World pageant in Hyderabad crowned Miss World 2025 after weeks of competition and cultural exchange.

Lab-grown bat organs, next stop on the road to predicting pandemics Premium

Discover how lab-grown bat organoids and cell lines are revolutionizing virus research and pandemic preparedness worldwide.

© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us